Search
for
Sort by
Research 271–300 of 1000+
- Absorption of Excess Selenium and Sulfur by Plants and Animals
- <i>De Novo</i> Design of Anti-Aging Peptides
- The human keratins: biology and pathology
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Is dehydroepiandrosterone a hormone?
- Treatment of invasive aspergillosis with itraconazole
- Stem Cells and the Niche: A Dynamic Duo
- Mesenchymal–epithelial interactions during hair follicle morphogenesis and cycling
- Polycystic Ovary Syndrome
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Roles of <i>jumonji</i> and <i>jumonji</i> family genes in chromatin regulation and development
- Cutaneous complications of chemotherapeutic agents
- Prostaglandin-Induced Hair Growth
- Drug-Induced Hair Loss and Hair Growth
- Vitamin D and the skin: Focus on a complex relationship: A review
- Hormone replacement therapy and the skin
- Estrogens and the skin
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Hormesis and medicine
- Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care
- Extrapulmonary disorders associated with Rhodococcus equi infection in foals: 150 cases (1987–2007)
- Finasteride induced depression: a prospective study
- Hyaluronidase Modulates Inflammatory Response and Accelerates the Cutaneous Wound Healing
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice
- Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
- Alopecia Areata Update
- Ritlecitinib: First Approval
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia